Results 31 to 40 of about 6,751 (146)
Neuropsychiatric Lyme Disease and Vagus Nerve Stimulation
Antibiotics, 2023 Lyme disease, the most common tick-borne disease in the United States, is caused by infection with the spirochete Borrelia burgdorferi. While most patients with acute Lyme disease recover completely if treated with antibiotics shortly after the onset of ...
Nicholas Biniaz-Harris +2 more
doaj +1 more source
Frontiers in Medicine, 2019 Introduction: The multi-system symptoms accompanying acute and post-treatment Lyme disease syndrome pose a challenge for time-limited assessment. The General Symptom Questionnaire (GSQ-30) was developed to fill the need for a brief patient-reported ...
Brian A. Fallon +14 more
doaj +1 more source
Frontiers in Medicine, 2020 Background: Longer time between symptom onset and treatment of Lyme disease has been associated with poor outcomes. Reducing time-to-treatment requires knowledge of risks for treatment delays.
Annemarie G. Hirsch +10 more
doaj +1 more source
Development of Low-Dose Disulfiram Rectal Suppository Intended for Application in Post-Treatment Lyme Disease Syndrome. [PDF]
PharmaceuticsBackground/Objectives: Early diagnosis and oral or, in severe cases, intravenous antibiotics are usually effective for Lyme disease, but some patients have persistent symptoms unresponsive to standards of care, requiring alternative therapies. Disulfiram (DIS), a drug for alcoholism, is under investigation as a potential adjunctive treatment, but its ...
Benkő BM +8 more
europepmc +3 more sources
Review paper Post-Lyme disease syndrome
Rheumatology, 2015 About 10% of patients with Lyme disease continue to experience musculoskeletal pain and cognitive dysfunction after recommended antibiotic treatment.
Joanna Ścieszka +2 more
doaj +1 more source
A reappraisal of the u.s. Clinical trials of post-treatment lyme disease syndrome. [PDF]
Open Neurol J, 2012 Four federally funded randomized placebo-controlled treatment trials of post-treatment Lyme syndrome in the United States have been conducted. Most international treatment guidelines summarize these trials as having shown no acute or sustained benefit to repeated antibiotic therapy.
Fallon BA +3 more
europepmc +5 more sources
Probable late lyme disease: a variant manifestation of untreated
BMC Infectious Diseases, 2012 Background Lyme disease, a bacterial infection with the tick-borne spirochete Borrelia burgdorferi, can cause early and late manifestations. The category of probable Lyme disease was recently added to the CDC surveillance case definition to describe ...
Aucott John N +2 more
doaj +1 more source
Indian Dermatology Online Journal, 2023 Lyme disease, a tick-borne multisystem disease, is caused by spirochete Borrelia burgdorferi (sensu lato). It is a common illness in temperate countries, especially the United States, but the incidence is increasing across continents due to increasing ...
Vikram K Mahajan
doaj +1 more source
Health care costs, utilization and patterns of care following Lyme disease.
PLoS ONE, 2015 BackgroundLyme disease is the most frequently reported vector borne infection in the United States. The Centers for Disease Control have estimated that approximately 10% to 20% of individuals may experience Post-Treatment Lyme Disease Syndrome - a set of
Emily R Adrion +3 more
doaj +1 more source
Infection Risk From Humans and Animals in the Anatomy Laboratory: A Scoping Review
Clinical Anatomy, EarlyView.ABSTRACT Whole‐body dissection is a cornerstone of anatomy education. During and following the COVID‐19 pandemic, exposure to infectious agents and other risks of dissection were highlighted. To identify potential risks, one must have the data outlining these risks in specific situations.
Margaret A. McNulty, Elizabeth R. Agosto
wiley +1 more source